Short description
InnaVirVax develops therapeutics, diagnostics, prevention aids, and prognostics for HIV, infectious diseases, and cancers.
Description
InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.
Last funding
No Way
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Évry, Ile-de-France, France, Europe
Founded on
January 1, 2008
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noway Youcantaccess
Sign in for full access
Founders
Patrice Debre